CLASS III ONGOING Drug recall · Reported 29 Jul 2026 · FDA Enforcement Report
Lidolog Kit, Kit Contains: Lidocaine HCl Injection recalled
Asclemed USA is recalling Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% vial, 1 Dose, Single use Only, distributed in Tennessee. The recall was initiated on 15 Jul 2026 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0713-2026
- FDA event ID
- 99408
- Recalling firm
- Asclemed USA, Torrance, CA
- Brand
- Lidolog Kit
- Manufacturer
- Asclemed USA, Inc.
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- 15 Jul 2026
- FDA classified
- 20 Jul 2026
- Reported
- 29 Jul 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Drug class
- Pain Medication
Timeline
| 15 Jul 2026 | Recall initiated by company | |
| 20 Jul 2026 | Classified by FDA | +5 days |
| 29 Jul 2026 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Product as listed by the FDA
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Where it was distributed
Within U.S. - Tennessee
Questions about this recall
Why was it recalled?
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Which lots are affected?
Lot: 070126X1, Exp. 12/31/2027.
Where was it sold?
Within U.S. - Tennessee
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Asclemed USA
All 10| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lidocaine HCl Injection USP, 1% (10 mg/mL) single dose ampule recalledLidocaine Hydrochloride | Asclemed USA | Sterility | Nationwide |
| Drug | CLASS II | Accucaine, Kit contains: Lidocaine HCl Injection recalledAccucaine | Asclemed USA | Sterility | Nationwide |
| Drug | CLASS II | Duloxetine DR Capsules, 30 mg, Rx, Relabeled recalled by Asclemed USADuloxetine | Asclemed USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS III | Asclemed USA products recalled | Asclemed USA | Other | AL, CA, LA |
| Drug | CLASS II | Estriol, USP, (Micronized) recalled by Asclemed USA | Asclemed USA | Potency & Assay | CA |
Other Lidocaine recalls
All 119| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg recalledXylocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Lidocaine HCl Injection, USP, 2%, 100 mg recalled by Fresenius Kabi USALidocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg recalledXylocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Lidocaine HCl Injection USP, 1% (10 mg/mL) single dose ampule recalledLidocaine Hydrochloride | Asclemed USA | Sterility | Nationwide |
| Drug | CLASS II | Accucaine, Kit contains: Lidocaine HCl Injection recalledAccucaine | Asclemed USA | Sterility | Nationwide |